Sign in

Cancer Progression and Metastasis Lab

@jackstadt-lab.bsky.social
455 followers 300 following 8 posts

We study mechanisms of cancer progression and metastasis - focus on colorectal cancer

PostsRepliesMedia
Reposted by Cancer Progression and Metastasis Lab
Chris Tape @christophertape.bsky.social · 24/09/2026
PhD opportunity in our lab at @ucl.ac.uk! 🧬 How do colorectal tumours spatially adapt to treatment? Study cancer cell plasticity using organoids, single-cell, & spatial biology. 4 years | Jan 2027 (flexible) | Stipend + UK home fees ucl.ac.uk/work-at-ucl/... Please share!
072
Reposted by Cancer Progression and Metastasis Lab
Nature Protocols @natprot.nature.com · 21/09/2026
New Article! Trace-n-Seq combines retrograde fluorescent tracing with sorting and single-cell sequencing of innervating peripheral neurons
dlvr.it
Trace-n-Seq combines retrograde fluorescent tracing with sorting and single-cell sequencing of innervating peripheral neurons
Nature Protocols, Published online: 21 September 2026; doi:10.1038/s41596-026-01416-zThis Protocol uses retrograde axonal tracing and fluorescence-activated cell sorting to transcriptionally profile innervating neurons at single-cell resolution.
032
Reposted by Cancer Progression and Metastasis Lab
Deutsches Krebsforschungszentrum (DKFZ) @dkfz.bsky.social · 17/09/2026
Dreaming of a career in cancer research? Join the International PhD Program at @DKFZ — Germany’s largest biomedical research center. Explore #cancerresearch including #cancerbiology, #bioinformatics, #epidemiology & #medicalphysics. The Winter Selection is open now 👉 apply t1p.de/hl56b
055
Reposted by Cancer Progression and Metastasis Lab
Healthcare in Europe (DE) @health-europe-de.bsky.social · 25/08/2026
Serratierte Läsionen sind eine spezielle Form von Darmpolypen, die zu besonders aggressiven und therapieresistenten #Tumoren führen. Forscher um @jackstadt-lab.bsky.social vom @dkfz.bsky.social und HI-STEM haben nun einen Mechanismus entdeckt, durch den dieser #Darmkrebs der Immunabwehr entkommt.
healthcare-in-europe.com
Wie aggressiver Darmkrebs dem Immunsystem entkommt
Forschende vom Deutschen Krebsforschungszentrum (DKFZ) und von Stammzell-Institut HI-STEM haben einen bislang unbekannten Mechanismus identifiziert, mit dem eine besonders aggressive Form von Darmkreb...
011
Reposted by Cancer Progression and Metastasis Lab
Deutsches Krebsforschungszentrum (DKFZ) @dkfz.bsky.social · 19/08/2026
Researchers from DKFZ and HI-STEM have identified a previously unknown mechanism by which a particularly aggressive form of colon cancer evades the immune system. The findings show that the activation of a key signaling pathway helps cancer cells suppress the immune system. t1p.de/an7f4
t1p.de
Colon Cancer: How Highly Aggressive Tumors Evade the Immune System
Researchers from the German Cancer Research Center (DKFZ) and the HI-STEM* Stem Cell Institute have identified a previously unknown mechanism by which a particularly aggressive form of colon cancer ev...
021
Reposted by Cancer Progression and Metastasis Lab
Hellmut Augustin @hellmutaugustin.bsky.social · 21/07/2026
Congratulations to Xiaowen Zhang for her spectacular publication in Cancer Discovery identifying a subpopulation of LPL-expressing intratumoral endothelial cells that decisively controls the anti-tumor immune response in liver metastases. See: aacrjournals.org/cancerdiscov...
043
Reposted by Cancer Progression and Metastasis Lab
Barbara Marte @barbmarte.bsky.social · 16/07/2026
new out in @nature www.nature.com/articles/s41...
nature.com
Modular in vivo antibody–ADC click to reverse drug resistance in tumours - Nature
In vivo ligation of clinically used therapeutic antibodies via bioorthogonal click chemistry to antibody–drug conjugates leads to enhanced antitumour activity in heterogeneous and treatment-resistant ...
042
Reposted by Cancer Progression and Metastasis Lab
Barbara Marte @barbmarte.bsky.social · 16/07/2026
and the News & Views to go with www.nature.com/articles/d41...
nature.com
A high-fat, low-carbohydrate diet can feed intestinal tumours
A ketogenic diet promotes tumour growth in the small intestine in susceptible mice. In people, diet advice might need to be tailored to individual cancer risks.
032
Reposted by Cancer Progression and Metastasis Lab
Barbara Marte @barbmarte.bsky.social · 16/07/2026
new out in @nature www.nature.com/articles/s41...
nature.com
Ketogenic diet mediates intestinal tumorigenesis through lipids not ketones - Nature
A combination of different manipulations in mouse models of spontaneous intestinal adenoma formation dissects the roles of systemic and epithelial ketogenesis versus dietary lipids in ketoge...
052
Reposted by Cancer Progression and Metastasis Lab
Slim Mzoughi @sleemmz.bsky.social · 13/07/2026
🔬 Come build something new with us in NYC 🗽. We're hiring a Postdoctoral Fellow and an Assistant Scientist at Mount Sinai. We study functional heterogeneity, cell-state plasticity, and tumor evolution, and we're looking for curious, ambitious scientists ready to tackle bold questions. Please share!
011
Reposted by Cancer Progression and Metastasis Lab
Deutsches Krebsforschungszentrum (DKFZ) @dkfz.bsky.social · 30/06/2026
#ERCPoC @moritzmall.bsky.social
131
Reposted by Cancer Progression and Metastasis Lab
Deutsches Krebsforschungszentrum (DKFZ) @dkfz.bsky.social · 30/06/2026
Through its "Proof of Concept" grants, the European Research Council (ERC) supports scientists in further developing the economic potential of their research findings. In 2026, two DKFZ-scientists were once again selected to receive this prestigious funding. 👏 #ERCPoC @erc.europa.eu t1p.de/nf8x3
t1p.de
Double ERC Success for DKFZ Researchers
Through its “Proof of Concept” (PoC) grants, the European Research Council (ERC) supports scientists in further developing the economic potential of their research findings. In 2026, two scientists fr...
162
Reposted by Cancer Progression and Metastasis Lab
EACR - European Association for Cancer Research @helloeacr.bsky.social · 22/06/2026
Already excited for next year's congress? Make sure to save the date in your calendars, and sign up for #EACR2027 updates! eepurl.com/dvcaQf
033
Reposted by Cancer Progression and Metastasis Lab
Cancer Cell @cp-cancercell.bsky.social · 16/06/2026
Antibody-drug conjugates in precision oncology
dlvr.it
Antibody-drug conjugates in precision oncology
In this review, Pistilli et al. examine persistent challenges in antibody-drug conjugate (ADC) development, including patient selection, biomarker validation, and preclinical modeling. Integrating emerging insights into tumor biology, resistance, and microenvironmental effects, the authors propose reframing ADCs as tumor-ecosystem-targeting therapies and outline paths to embed ADCs within precision oncology.
042
Reposted by Cancer Progression and Metastasis Lab
Eric Topol @erictopol.bsky.social · 31/05/2026
There hasn't previously been a treatment vs pancreatic cancer this successful. Striking improved (a doubling) survival results @nejm.org and @ascocancer.bsky.social published today with daraxonrasib, which also became available via an FDA-approved early access program nejm.org/doi/full/10....
7506144
Reposted by Cancer Progression and Metastasis Lab
Mick Milsom @milsommick.bsky.social · 25/05/2026
How do lineage-biased HSC states relate to each other? check out: rdcu.be/fkASJ in @natcellbio.nature.com Collaboration with @simonhaas.bsky.social @bihatcharite.bsky.social & MDC; Thomas Höfer & Daniel Hübschmann @dkfz.bsky.social @nct-heidelberg.bsky.social
3228
Reposted by Cancer Progression and Metastasis Lab
Simon Haas @simonhaas.bsky.social · 26/05/2026
In our new study, we identify stem cell kinetics and cellular competition as key principles underlying hematopoietic stem cell diversity. Fun collab@milsommick.bsky.social Florian Grünschläger@estherrodriguezc.bsky.social, Tamar Nizharadze, T. Höfer, D. Hübschmann(1/6) www.nature.com/articles/s41...
185
Reposted by Cancer Progression and Metastasis Lab
EACR - European Association for Cancer Research @helloeacr.bsky.social · 15/05/2026
EACR Travel Grant winners share their reflections on attending the most recent edition of our cutting-edge The Tumour Ecosystem conference, including what they learned and how the experience supported their research journey. Read the full article here: magazine.eacr.org/eacr-travel-...
031
Reposted by Cancer Progression and Metastasis Lab
SFB/TRR 417 @trr417.bsky.social · 13/05/2026
💬 Join us for a CRC Crosstalk Seminar 💬 “Decoding and targeting cellular dynamics in colorectal cancer metastasis” with Dr. Rene Jackstadt (@jackstadt-lab.bsky.social), from HI-STEM gGmbH and @dkfz.bsky.social 📅 Wed, May 20, 2026 🕙 12:00 pm 📍 Lecture Hall, Georg-Speyer-Haus FFM / Hybrid
052
Reposted by Cancer Progression and Metastasis Lab
Deutsches Krebsforschungszentrum (DKFZ) @dkfz.bsky.social · 08/05/2026
Moritz Mall, DKFZ and HITBR, has been awarded the Sibylle Assmus Foundation’s Neuro-Oncology Prize for his research on the plasticity of malignant brain tumors and how this can be used as a potential therapeutic approach. Congratulations! 👏 @moritzmall.bsky.social t1p.de/p49cb
t1p.de
The Plasticity of Malignant Brain Tumors as a Potential Therapeutic Approach: Sibylle Assmus Prize for Neuro-Oncology Awarded to Moritz Mall
The ability of cancer cells to change their identity makes tumors such as glioblastoma particularly aggressive and resistant to treatment. Moritz Mall, of the German Cancer Research Center (DKFZ) and ...
1134
Reposted by Cancer Progression and Metastasis Lab
Nature Cancer @natcancer.nature.com · 05/05/2026
🔥Online now, a Review on EMT as driver of tumor cell plasticity By @nietoangela.bsky.social and @ruljcz.bsky.social Part of our Series on Tumor Heterogeneity and Plasticity: nature.com/collections/... nature.com/articles/s43...
nature.com
Epithelial-to-mesenchymal transition as a central driver of tumor cell plasticity - Nature Cancer
Jimenez-Castaño and Nieto review the latest research on cellular plasticity associated with epithelial–mesenchymal transition (EMT) states in cancer cells, highlighting the contributions of EMT to tum...
072
Reposted by Cancer Progression and Metastasis Lab
Aguirre-Ghiso Lab @jaguirreghisolab.bsky.social · 03/05/2026
Exciting findings showing that DEC2 coordinates dormancy and immune-evasion in PDAC further linking it to circadian regulation. We revealed DEC2 function in cancer dormancy in two papers in 2009 and 2013. Great to see this biology expanded to PDAC. Congrats! www.cell.com/developmenta...
011
Reposted by Cancer Progression and Metastasis Lab
EACR - European Association for Cancer Research @helloeacr.bsky.social · 29/04/2026
"I am in constant contact with EACR members both locally (through my institution) and internationally. We write grants and projects together (and papers when it comes!) and we even had some personnel exchanges." - Chiara Ambrogio, an EACR member and Board member
021
Reposted by Cancer Progression and Metastasis Lab
IRB Barcelona @irbbarcelona.org · 29/04/2026
🧪 New biomarker to determine whether #immunotherapy may work in people with colon & rectal #cancer. 🔬A study by @researchmar.bsky.social& #IRBBarcelona, published in the journal Gut. ➡️ shorturl.at/iUXky 📌DOI: dx.doi.org/10.1136/gutjnl-2025-3368… @batllelab.bsky.social
031
Reposted by Cancer Progression and Metastasis Lab
Karsten Rippe @karsten-rippe.bsky.social · 20/04/2026
1/ Philipp Mallm from the @dkfz.bsky.social Single-cell Open Lab just broke the news at #AACR26: the first results on colorectal cancer (CRC) tissue analysis with the new Atera spatial transcriptomics platform from @10xgenomics.bsky.social. Is it "making the impossible possible?" 🧵
32610
Reposted by Cancer Progression and Metastasis Lab
Francesco Baschieri @fbaschieri.bsky.social · 20/04/2026
Inspiring article! An absolute must-read
173
Reposted by Cancer Progression and Metastasis Lab
Chris Tape @christophertape.bsky.social · 31/03/2026
We are recruiting! We are searching for an exceptional postdoctoral fellow to lead the single-cell phenoscaping efforts of the REWIRE-CAN Cancer Grand Challenge @cancergrand.bsky.social For more information and to apply please visit: www.ucl.ac.uk/work-at-ucl/...
097
Reposted by Cancer Progression and Metastasis Lab
omartin-bio.bsky.social @omartin-bio.bsky.social · 22/03/2026
🚨 Early-bird deadline approaching! 1st of April... 🔬 Discover cutting-edge research 🤝 Connect with peers and experts 💡 Exclusive "Meet" the editor session 🏆 Awards for the best oral and poster presentations for young researchers @sunrise-network.bsky.social
012
Reposted by Cancer Progression and Metastasis Lab
Netherlands Cancer Institute @nkinl.bsky.social · 20/02/2026
We;re hiring Junior Group Leaders! 🔬✨ We’re looking for researchers in immunology, chemical biology, AI in biology, or protein design to launch their own independent groups in our collaborative, international environment. www.nki.nl/news-events/...
01829
Reposted by Cancer Progression and Metastasis Lab
Deutsches Krebsforschungszentrum (DKFZ) @dkfz.bsky.social · 18/02/2026
Researchers from the DKFZ, HI-STEM stem cell institute and the biotech company Xilis in Utrecht, Netherlands, have developed a new method for selecting the most effective drug for advanced colorectal cancer before treatment begins. The method is based on tiny 3D tumor models. t1p.de/c1gdx
t1p.de
3D microtumors could revolutionize treatment decisions
Chemotherapy is often a central component of treatment for advanced colorectal cancer. However, not every therapy is equally effective for every patient. Researchers from the German Cancer Research Ce...
042
Reposted by Cancer Progression and Metastasis Lab
Andreas Moor @andreasmoor.bsky.social · 16/02/2026
join our faculty at D-BSSE, ETHZ in Basel, Switzerland! New assistant prof position (tenure-track) in computational immunology, please share or apply. ethz.ch/en/the-eth-z...
ethz.ch
Assistant Professor (Tenure Track) of Computational Immunology
197
Reposted by Cancer Progression and Metastasis Lab
Nature Reviews Cancer @natrevcancer.nature.com · 13/02/2026
🥳And coming it at number 1🥁🥁🥁.... Our 1st most downloaded #REVIEW in 2025: Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment #ADCs #antibodydrugconjugates @NatResCancer #NRCtop10of2025
dlvr.it
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment - Nature Reviews Cancer
Antibody–drug conjugates are rapidly expanding both in the clinical treatment of cancer and in preclinical development. In this Review, Zippelius et al. highlight the molecular interactions and immune system effects of these sophisticated drugs that drive their efficacy and toxicity.
031
Reposted by Cancer Progression and Metastasis Lab
Quaid Morris @quaidmorris.bsky.social · 29/01/2026
In a new paper, we introduce Metient, a new method to reconstruct the migration history of metastatic clones, and learn cancer-type specific patterns of metastatic spread, from bulk or single-cell sequencing data. www.nature.com/articles/s41...
nature.com
Inferring cancer type-specific patterns of metastatic spread using Metient - Nature Methods
Metient is a statistical framework that infers patterns of metastatic spread and reconstructs cancer migration histories.
53513
Reposted by Cancer Progression and Metastasis Lab
ZMBH @zmbh.uni-heidelberg.de · 19/12/2025
We invite applications for a Tenure Track Professorship (W1->W3) in Molecular Biology @ZMBH. We are looking for excellent postdocs, ready to start their own research group. Feel free to spread the news by reposting. Applications can be filed until January 18th. www.nature.com/naturecareer...
nature.com
Tenure Track Professorship (W1 with Tenure Track to W3) in “Molecular Biology" (f/m/d) - Heidelberg job with Universität Heidelberg | 12850668
The Center for Molecular Biology of Heidelberg University (ZMBH) and the Faculty of Biosciences invite applications for a   Tenure Track Professors...
062
Reposted by Cancer Progression and Metastasis Lab
Deutsches Krebsforschungszentrum (DKFZ) @dkfz.bsky.social · 27/01/2026
Vielen Dank für den Besuch! #ForschenfüreinLebenohneKrebs
021
Reposted by Cancer Progression and Metastasis Lab
SUNRiSE network @sunrise-network.bsky.social · 27/01/2026
8e Formation SUNRiSE : 2 & 3 mars 2026! Venez vous former aux technologies récentes pour étudier les cellules souches cancéreuses et la plasticité tumorale auprès d'experts dans le domaine! Informations ici: www.sunrise-network.fr/fr/event/7e-...
sunrise-network.fr
8e Formation SUNRiSE : 2 & 3 mars 2026 - Sunrise
HETEROGENEITE ET PLASTICITE TUMORALE : LES NOUVELLES TECHNOLOGIES POUR EXPLORER L’ECOSYSTEME TUMORAL 8e SESSION DE FORMATION DU RESEAU SUNRiSE 2 au 3 mars 2026, On line Objectif : Cette formation se d...
011
Reposted by Cancer Progression and Metastasis Lab
Elizabeth McKenna @elizsmckenna.bsky.social · 23/01/2026
by William Cross, Salpie Nowinski, George Cresswell, Maximilian Mossner, Abhirup Banerjee, Bingxin Lu, Andrea Sottoriva, @trevorgraham.bsky.social, et al. @cec-icr.bsky.social @icr.ac.uk @humantechnopole.bsky.social
031
Reposted by Cancer Progression and Metastasis Lab
IRB Barcelona @irbbarcelona.org · 19/01/2026
📌 This Friday at #IRBBarcelona: plenary #seminar with Dr. Rocío Sotillo, from the DKFZ German Cancer Research Center (@dkfz.bsky.social).  Host: Dr. Lluís Ribas 🔗 Register here: shorturl.at/tY30N #IRBBarcelona #CancerResearch #Seminar 🧪
071
Reposted by Cancer Progression and Metastasis Lab
Trevor Graham @trevorgraham.bsky.social · 19/01/2026
Open postdoc position in our lab @icr.ac.uk to develop a cfDNA test for #early detection of colorectal #cancer in inflammatory bowel disease #IBD: jobs.icr.ac.uk/vacancies/14... It's bench-to-bedside research, translating biology of pre-cancer evolution. Funded by @bowelcanceruk.bsky.social
jobs.icr.ac.uk
Postdoctoral Training Fellow - Genomics and Evolutionary Dynimcs in Sutton | The Institute of Cancer Research
View details and apply for this Postdoctoral Training Fellow - Genomics and Evolutionary Dynimcs vacancy in Sutton. Salary: Dependent on relevant Postdoctoral experience. Durati...
0139
Reposted by Cancer Progression and Metastasis Lab
Metastasis Research Society @metastasisresearch.bsky.social · 10/01/2026
Register for our next ECLC webinar by Aeson Chang, PhD on 'Breast cancer got the nerves to resist chemotherapy' - January 15th, 2026 - USA: 5:00 PM EST | Europe: 11:00 PM CET | January 16th, Australia: 09:00 AM AEDT - bit.ly/44APSVI
132
Reposted by Cancer Progression and Metastasis Lab
Trevor Graham @trevorgraham.bsky.social · 07/01/2026
With the start of our new study trying to find causes of bowel cancer in young people hitting the headlines today: www.bbc.co.uk/news/article... I'm so glad to see bold efforts to raise awareness, like this giant 5x3m poster on the Croydon station platform I pass by on my to the lab each day
0193
Reposted by Cancer Progression and Metastasis Lab
School of Cancer Sciences @uofgcancersciences.bsky.social · 16/12/2025
We are hiring! Professor of Epithelial Stem Cell Biology & Cancer (Ref 189213) - Closing Date 7th Jan 2026 www.jobs.gla.ac.uk/job/professo... 🔬
jobs.gla.ac.uk
Professor Epithelial Stem Biology & Cancer
Job Purpose To take a senior leadership role by conducting internationally leading research, with specific interests in cancers of epithelial origin, the role of epithelial stem cells in tissue hom...
153
Reposted by Cancer Progression and Metastasis Lab
Thomas R. Cox @trcox.matrixandmetastasis.com · 10/12/2025
We're looking for a Research Assistant / Senior Research Assistant to join our team. If you're interested in studying the extracellular matrix and tumour microenvironment in cancer, then get in touch. Applications will be reviewed on a rolling basis. garvan.wd3.myworkdayjobs.com/garvan_insti...
045
Reposted by Cancer Progression and Metastasis Lab
corderolab.bsky.social @corderolab.bsky.social · 08/12/2025
A 4-year fully funded international PhD project in the lab in collaboration with Johan Vande Voorde. Apply if you are interested in working on an exciting project on CRC and interorgan communication in flies and mice. www.crukscotlandinstitute.ac.uk/cruk-si-educ...
crukscotlandinstitute.ac.uk
Interorgan communication in Colorectal Cancer
022
Reposted by Cancer Progression and Metastasis Lab
Deutsches Krebsforschungszentrum (DKFZ) @dkfz.bsky.social · 25/11/2025
Dreaming of a career in cancer research? Join the International PhD Program at DKFZ - Germany’s largest biomedical research center. Explore #cancerresearch including #cancerbiology, #bioinformatics, #epidemiology & #medicalphysics. The Winter Selection is open now 👉 apply t1p.de/hl56b
032
Reposted by Cancer Progression and Metastasis Lab
SUNRiSE network @sunrise-network.bsky.social · 17/11/2025
Join us for our next meeting in Bordeaux, from the 26th to the 28th May 2026 sunrisemeeting.sciencesconf.org
sunrisemeeting.sciencesconf.org
6th sunrise meeting : Heterogeneity and Plasticity in cancer - Sciencesconf.org
The 6th Sunrise Meeting
011
Reposted by Cancer Progression and Metastasis Lab
Deutsches Krebsforschungszentrum (DKFZ) @dkfz.bsky.social · 05/11/2025
🚀 Thinking about your next big career step in science? The Int'l PhD Program at DKFZ could be a perfect fit for you. 🌍 Work in an international environment, with 500+ doctoral researchers 🔬 Do cutting-edge cancer research Curious? Join our online info session on 20 Nov. Register here: t1p.de/ws7q3
0910
Reposted by Cancer Progression and Metastasis Lab
Johannes Zuber @johanneszuber.bsky.social · 10/11/2025
Become our colleague! Apply for Junior Group Leader positions at @impvienna.bsky.social!
061
Reposted by Cancer Progression and Metastasis Lab
Metastasis Research Society @metastasisresearch.bsky.social · 10/11/2025
⏰ It’s almost here! The ECR Virtual Meeting kicks off next week, connecting ECRs shaping the future of metastasis biology. 💡 Inspiring talks from rising leaders 💬 Community-led discussions 🌍 A truly global metastasis community 🗓️ Last chance to register ➜ bit.ly/4qyxE0o 📘 Program ➜ bit.ly/4qtpVR9
metastasis-research.org
2nd MRS Early Career Research Virtual Meeting | Metastasis Research
The 2025 MRS Early Career Research Virtual Meeting is a two day meeting aimed at engaging trainees and early career researchers from around the world and highlighting recent advances in metastasis research through keynote presentations, invited talks, panel discussions, and selected talks from abstracts. The meeting is organized and hosted by the Early Career Leadership Council (ECLC) of the MRS. Abstracts are being accepted for consideration for oral presentations. Abstract submission is open to graduate students, postdoctoral fellows, medical students, residents, clinical fellows, and researchers within 3 years of starting their own independent research group. Registration for this meeting is free for MRS Members!
052
Reposted by Cancer Progression and Metastasis Lab
Trevor Graham @trevorgraham.bsky.social · 05/11/2025
New @natgenet.nature.com paper from the brilliant @eszterlakatos.bsky.social presents evidence that chromatin alterations disrupt antigen presentation & neoantigens in colorectal cancer. Also that immune escape is part of the "Big Bang", at the outset of CRC growth. www.nature.com/articles/s41...
nature.com
Epigenetically driven and early immune evasion in colorectal cancer evolution - Nature Genetics
This study nominates immune escape as an early event in colorectal cancer and shows how this can be driven through both genetic and epigenetic changes.
23011